IPO registrations (S-1, F-1) · Registrants

Yarrow Bioscience, Inc.

SEC CIK

1566044 · filings on EDGAR ↗

Name on the registration

Menlo Therapeutics, Inc.

Former names

VYNE Therapeutics Inc. (2020–2026); Menlo Therapeutics Inc. (2017–2020); Menlo Therapeutics, Inc. (2017–2018); Tigercat Pharma, Inc. (2013–2013)

Registration

Form S-1, first filed 2017-12-28, last 2018-01-23; 1 initial registration, 3 amendments

Outcome

Final prospectus filed 2018-01-26; declared effective 2018-01-24

Industry (SIC)

Pharmaceutical Preparations 2834

Incorporated in

DE

Business address

470 JAMES STREET, SUITE 007, New Haven, CT 06513

EIN

45-3757789

Ticker

YARW (Nasdaq)

EDGAR entity type

operating

Insiders and CEO pay

Yarrow Bioscience, Inc. on the corporate pages

Offering terms

Proposed price range

$16.00–$17.00 per share (S-1/A filed 2018-01-23)

Final price

$17.00 per share, within the range (424B4 filed 2018-01-26, an initial public offering)

Shares sold

7,000,000

Gross proceeds

$119,000,000 before underwriting discounts and any over-allotment option

Listing

Nasdaq under the symbol MNLO

Lead underwriters

Jefferies (2,625,000 shares); Piper Sandler (2,100,000 shares); Guggenheim Securities (1,400,000 shares)

Syndicate

JMP Securities (875,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

On this site

• Business registration: YARROW BIOSCIENCE, INC. Fuzzy (name and state)
• Form 5500 plan sponsor: MENLO THERAPEUTICS INC. EXACT (EIN (EXACT))
• Form D issuer: VYNE Therapeutics Inc. EXACT (CIK (EXACT))
• SEC filer: Menlo Therapeutics Inc. EXACT (CIK (EXACT))
• Person page: Dr Scott M Whitcup MD Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
• Person page: Mr Patrick G Lepore Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))

Filings 9

Prospectus pages read 2

Officers, directors and large holders Forms 3, 4 and 5

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, CT first:

• CHIREX INC CT
• ACHILLION PHARMACEUTICALS INC CT
• Rib-X Pharmaceuticals, Inc. CT
• Oracle Healthcare Acquisition Corp. CT
• NANOVIRICIDES, INC. CT
• KOLLTAN PHARMACEUTICALS INC CT
• Trevi Therapeutics, Inc. CT
• Loxo Oncology, Inc. CT
• ARVINAS, INC. CT
• Biohaven Pharmaceutical Holding Co Ltd. CT

More with this interest.

In other datasets, the same topic (Health) in CT:

• Nonprofit: AIDS BUDDY NETWORK (Nonprofits (IRS Form 990))

Interests: Pharmaceutical Preparations · Health